TipRanks
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market

Compare Actuate Therapeutics, Inc. (ACTU) vs. Competitors

54 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Actuate Therapeutics, Inc.
$1.78
$16.31M
-0.70
-90.31%
2 Buy
0 Hold
0 Sell
Moderate Buy
Tempest Therapeutics
$1.08
$13.01M
-0.17
-92.99%
1 Buy
0 Hold
0 Sell
Moderate Buy
Actinium Pharmaceuticals
$1.08
$33.96M
3.11
-29.87%
2 Buy
0 Hold
0 Sell
Moderate Buy
Cellectar Biosciences
$2.54
$13.23M
-0.32
-70.71%
3 Buy
0 Hold
0 Sell
Strong Buy
Marker Therapeutics
$1.52
$15.84M
-2.02
-12.04%
2 Buy
0 Hold
0 Sell
Moderate Buy
Lantern Pharma
$2.18
$12.40M
-0.51
-81.92%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACTU
Actuate Therapeutics, Inc.
0.68
-7.11
-91.28%
TPST
Tempest Therapeutics
0.77
-9.50
-92.50%
ATNM
Actinium Pharmaceuticals
1.08
-0.41
-27.52%
CLRB
Cellectar Biosciences
1.40
-3.24
-69.83%
MRKR
Marker Therapeutics
0.95
-0.06
-5.94%
LTRN
Lantern Pharma
0.83
-3.51
-80.88%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts